These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19330026)

  • 1. Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.
    Kwek SS; Roy R; Zhou H; Climent J; Martinez-Climent JA; Fridlyand J; Albertson DG
    Oncogene; 2009 Apr; 28(17):1892-903. PubMed ID: 19330026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei.
    Bautista S; Theillet C
    Genes Chromosomes Cancer; 1998 Aug; 22(4):268-77. PubMed ID: 9669664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.
    Karlsson E; Waltersson MA; Bostner J; Pérez-Tenorio G; Olsson B; Hallbeck AL; Stål O
    Genes Chromosomes Cancer; 2011 Oct; 50(10):775-87. PubMed ID: 21748818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.
    Garcia MJ; Pole JC; Chin SF; Teschendorff A; Naderi A; Ozdag H; Vias M; Kranjac T; Subkhankulova T; Paish C; Ellis I; Brenton JD; Edwards PA; Caldas C
    Oncogene; 2005 Aug; 24(33):5235-45. PubMed ID: 15897872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event.
    Paterson AL; Pole JC; Blood KA; Garcia MJ; Cooke SL; Teschendorff AE; Wang Y; Chin SF; Ylstra B; Caldas C; Edwards PA
    Genes Chromosomes Cancer; 2007 May; 46(5):427-39. PubMed ID: 17285574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive profiling of 8p11-12 amplification in breast cancer.
    Gelsi-Boyer V; Orsetti B; Cervera N; Finetti P; Sircoulomb F; Rougé C; Lasorsa L; Letessier A; Ginestier C; Monville F; Esteyriès S; Adélaïde J; Esterni B; Henry C; Ethier SP; Bibeau F; Mozziconacci MJ; Charafe-Jauffret E; Jacquemier J; Bertucci F; Birnbaum D; Theillet C; Chaffanet M
    Mol Cancer Res; 2005 Dec; 3(12):655-67. PubMed ID: 16380503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers.
    Głodzik D; Purdie C; Rye IH; Simpson PT; Staaf J; Span PN; Russnes HG; Nik-Zainal S
    Ann Oncol; 2018 Nov; 29(11):2223-2231. PubMed ID: 30252041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
    Lundgren K; Holm K; Nordenskjöld B; Borg A; Landberg G
    Breast Cancer Res; 2008; 10(5):R81. PubMed ID: 18823530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines.
    Ray ME; Yang ZQ; Albertson D; Kleer CG; Washburn JG; Macoska JA; Ethier SP
    Cancer Res; 2004 Jan; 64(1):40-7. PubMed ID: 14729606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.
    Holm K; Staaf J; Jönsson G; Vallon-Christersson J; Gunnarsson H; Arason A; Magnusson L; Barkardottir RB; Hegardt C; Ringnér M; Borg A
    Breast Cancer Res Treat; 2012 Jun; 133(2):583-94. PubMed ID: 22002566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.
    Letessier A; Sircoulomb F; Ginestier C; Cervera N; Monville F; Gelsi-Boyer V; Esterni B; Geneix J; Finetti P; Zemmour C; Viens P; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Chaffanet M
    BMC Cancer; 2006 Oct; 6():245. PubMed ID: 17040570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas.
    Reis-Filho JS; Simpson PT; Turner NC; Lambros MB; Jones C; Mackay A; Grigoriadis A; Sarrio D; Savage K; Dexter T; Iravani M; Fenwick K; Weber B; Hardisson D; Schmitt FC; Palacios J; Lakhani SR; Ashworth A
    Clin Cancer Res; 2006 Nov; 12(22):6652-62. PubMed ID: 17121884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming properties of 8p11-12 amplified genes in human breast cancer.
    Yang ZQ; Liu G; Bollig-Fischer A; Giroux CN; Ethier SP
    Cancer Res; 2010 Nov; 70(21):8487-97. PubMed ID: 20940404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocation and coamplification of loci from chromosome arms 8p and 11q in the MDA-MB-175 mammary carcinoma cell line.
    Adélaïde J; Chaffanet M; Mozziconacci MJ; Popovici C; Conte N; Fernandez F; Sobol H; Jacquemier J; Pébusque M; Ron D; Lafage-Pochitaloff M; Birnbaum D
    Int J Oncol; 2000 Apr; 16(4):683-8. PubMed ID: 10717235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.
    Janssen JW; Cuny M; Orsetti B; Rodriguez C; Vallés H; Bartram CR; Schuuring E; Theillet C
    Int J Cancer; 2002 Dec; 102(6):608-14. PubMed ID: 12448002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
    Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
    J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.
    Brown LA; Irving J; Parker R; Kim H; Press JZ; Longacre TA; Chia S; Magliocco A; Makretsov N; Gilks B; Pollack J; Huntsman D
    Gynecol Oncol; 2006 Feb; 100(2):264-70. PubMed ID: 16236351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.
    Chin SF; Teschendorff AE; Marioni JC; Wang Y; Barbosa-Morais NL; Thorne NP; Costa JL; Pinder SE; van de Wiel MA; Green AR; Ellis IO; Porter PL; Tavaré S; Brenton JD; Ylstra B; Caldas C
    Genome Biol; 2007; 8(10):R215. PubMed ID: 17925008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma.
    Hui AB; Or YY; Takano H; Tsang RK; To KF; Guan XY; Sham JS; Hung KW; Lam CN; van Hasselt CA; Kuo WL; Gray JW; Huang DP; Lo KW
    Cancer Res; 2005 Sep; 65(18):8125-33. PubMed ID: 16166286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who is in the driver's seat in 8p12 amplifications? ZNF703 in luminal B breast tumors.
    Bazarov AV; Yaswen P
    Breast Cancer Res; 2011 May; 13(3):308. PubMed ID: 21635707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.